OS THERAPIES INC (OSTX) Stock Price, Quote, News and Summary
NYSEARCA:OSTX - American Stock Exchange - US68764Y2072 - Common Stock
OSTX Quote and Key Statistics
OS THERAPIES INC
NYSEARCA:OSTX (1/17/2025, 3:43:48 PM)
3.0069
-1.11 (-27.02%)
OSTX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -375.2% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OSTX Performance and Technical Analysis
OSTX Ownership and Analysts
OSTX Latest News and Analysis
Let's take a look at the stocks that are in motion in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
What's going on in today's session
Which stocks are experiencing notable movement on Friday?
Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?
OS Therapies shares Phase 2b trial results showing OST-HER2 improves survival rates in rare metastatic osteosarcoma, surpassing historical controls.
OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference
About OSTX
Company Profile
OS Therapies Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2024-08-01. OS Therapies Incorporated is a clinical-stage biopharmaceutical company. The firm is focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company built a pipeline of product candidates targeting multiple indications for solid cancers. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. OST-HER2 is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH sensitive silicone linkers (SiLinkers). The payloads can include antibodies, chemotherapeutics, cytotoxins and potentially mRNA treatments directly into and in the vicinity of solid tumors.
Company Info
OS THERAPIES INC
15825 Shady Grove Road, Suite 135
Rockville MARYLAND US
Employees: 4
Company Website: https://ostherapies.com/
Phone: 14102977793
OSTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.96 | 303.15B | ||
| AMGN | AMGEN INC | 14.19 | 146.56B | ||
| GILD | GILEAD SCIENCES INC | 20.78 | 114.74B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 832.67 | 109.36B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.03 | 75.05B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.48B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.71B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.17B | ||
| ONC | BEIGENE LTD-ADR | N/A | 22.34B | ||
| NTRA | NATERA INC | N/A | 21.21B | ||
| BIIB | BIOGEN INC | 8.61 | 20.48B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.72 | 15.98B |